Disease manifestations and X inactivation in heterozygous females with Fabry disease

被引:94
|
作者
Maier, Esther M.
Osterrieder, Stephanie
Whybra, Catharina
Ries, Markus
Gal, Andreas
Beck, Michael
Roscher, Adelbert A.
Muntau, Ania C. [1 ]
机构
[1] Univ Munich, Dr Von Hauner Childrens Hosp, Res Ctr, Dept Biochem Genet & Mol Biol, D-80337 Munich, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Pediat, D-6500 Mainz, Germany
[3] NIH, Dev & Metab Neurol Branch, Bethesda, MD 20892 USA
[4] Univ Hamburg, Med Ctr Eppendorf, Hamburg, Germany
关键词
Fabry disease; lysosomal storage disorder; heterozygotes; X inactivation; HUMARA assay;
D O I
10.1080/08035320600618809
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: Fabry disease is an X-linked lysosomal storage disorder characterized by an accumulation of neutral glycosphingolipids in multiple organ systems caused by alpha-galactosidase A deficiency due to mutations in the GLA gene. The majority of heterozygous females show the characteristic signs and symptoms of the disease, and some of them are severely affected. The current hypothesis for the occurrence of disease manifestations in females is skewed X inactivation favouring the mutant GLA allele. Method: We analyzed the patterns of X inactivation in the leukocytes of 28 biochemically and genetically characterized symptomatic Fabry disease heterozygotes and their correlation with clinical and biochemical disease expression. Results: X inactivation patterns in symptomatic females who are heterozygous for Fabry disease did not differ from those of female controls of the same age (p = 0.669). Thirteen (46%) of the 28 females with Fabry disease showed random X inactivation, ten (36%) moderate skewing, and five (18%) highly skewed X inactivation. Segregation analysis was performed in the families of six females who had highly or moderately skewed X inactivation. In four of these females, skewing favoured the wild-type GLA allele and in the other two skewing favoured the mutant allele. Patterns of X inactivation or the extent of skewing were not related to the severity of clinical manifestations or to residual enzyme activity. Conclusion: In this study we provide evidence that heterozygous females with Fabry disease show random X inactivation. Our data do not support the hypothesis that the occurrence and severity of disease manifestations in the majority of Fabry heterozygotes are related to skewed X inactivation.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [21] Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
    Baehner, F
    Kampmann, C
    Whybra, C
    Miebach, E
    Wiethoff, CM
    Beck, M
    JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) : 617 - 627
  • [22] Heterozygous Fabry females suffer from significant multisystemic disease and impairment in quality of life
    Wang, R. W.
    Lelis, A.
    Wilcox, W. R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 22 - 22
  • [23] Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
    MacDermot, KD
    Holmes, A
    Miners, AH
    JOURNAL OF MEDICAL GENETICS, 2001, 38 (11) : 769 - 775
  • [24] Ocular manifestations of Fabry disease
    Bar, DA
    Holzman, PC
    Cremonini, PS
    Chamoles, NA
    Badia, JA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U510 - U510
  • [25] Fabry disease - Vascular manifestations
    Karetova, D.
    Bultas, J.
    Dostalova, G.
    Palecek, T.
    Kovarnik, T.
    Golan, L.
    Linhart, A.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2010, 39 (02) : 123 - 131
  • [26] Cardiological Manifestations of Fabry Disease
    Leitner, H.
    JOURNAL FUR KARDIOLOGIE, 2019, 26 (1-2): : 40 - 41
  • [27] Neurological manifestations of Fabry disease
    Mendioroz, M.
    Fernandez-Cadenas, I.
    Montaner, J.
    REVISTA DE NEUROLOGIA, 2006, 43 (12) : 739 - 745
  • [28] Pulmonary manifestations of Fabry disease
    Latshang, T
    Schulthess, G
    Aubert, JD
    Widmer, U
    ACTA PAEDIATRICA, 2006, 95 : 122 - 122
  • [29] GASTROINTESTINAL MANIFESTATIONS OF FABRY DISEASE
    WERLIN, SL
    SHETH, KJ
    FREEMAN, ME
    HODACH, AE
    GASTROENTEROLOGY, 1980, 78 (05) : 1290 - 1290
  • [30] Cardiac manifestations in Fabry disease
    Linhart, A
    Lubanda, JC
    Palecek, T
    Bultas, J
    Karetová, D
    Ledvinová, J
    Elleder, M
    Aschermann, M
    JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 : 75 - 83